Premium
Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency
Author(s) -
Lipworth Wendy L,
Ho Ken,
Kerridge Ian H,
Day Richard O
Publication year - 2012
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja11.11572
Subject(s) - medicine , library science , management , computer science , economics
The Medical Journal of Australia ISSN: 0025729X 20 August 2012 197 4 204-204 ©The Medical Journal of Australia 2012 www.mja.com.au Perspective energy, and reduce the use of health services.1,2 While for reasons that will be discussed below, there is limite evidence of the effects of GH replacement on mortalit extrapolation from the improvement in lipid profile al would suggest that cardiovascular mortality may be reduced as a result of GH replacement. Consensus guidelines from leading international Are current standards of evidence always appropriate when making the decision to subsidise treatment?